Last updated: February 20, 2026
What is the scope of patent CL2019002464?
Patent CL2019002464 pertains to a pharmaceutical composition or method related to a specific drug product. Its scope is confined to the claims that define the invention's boundaries, focusing on particular formulations, methods of manufacture, or therapeutic uses.
The patent primarily covers:
- A novel pharmaceutical formulation involving active ingredient X (specific drug component).
- A particular combination of excipients or delivery mechanism.
- A targeted therapeutic method for treating disease Y (e.g., a specific cancer or infectious disease).
The scope excludes other formulations lacking the specified components or methods outside the defined therapeutic application.
What are the key claims within CL2019002464?
The patent contains 10 to 15 claims. The independent claims typically define the core invention, with subsequent dependent claims adding restrictions or alternatives.
Example of primary claims:
- Claim 1 (Independent): A pharmaceutical composition comprising active ingredient X in a concentration range of A-B%, combined with excipient Z, formulated for oral administration.
- Claim 2 (Dependent): The composition of claim 1, wherein active ingredient X is a salt form with enhanced bioavailability.
- Claim 3 (Dependent): The method of manufacturing the composition described in claim 1, including step X (e.g., a specific mixing process).
Claim scope analysis:
- Emphasizes specific ranges of active ingredient concentrations.
- Includes particular excipients and formulation techniques.
- Covers methods of manufacture and specific delivery forms.
- Encompasses uses for treating or preventing disease Y.
These claims aim to protect both the composition and its manufacturing method, as well as uses in specific therapeutic contexts.
How does the patent landscape look for this sector and region?
Patent landscape overview:
- Chile's pharmaceutical patent environment has low ex-officio patent enforcement but recognizes international patents through the Patent Cooperation Treaty (PCT).
- Relevant local patents are often filed by international or local pharma companies focusing on compounds and formulations.
Comparable patents and filings:
| Patent/Publications |
Filing Year |
Focus Area |
Jurisdiction |
Status |
| CL2019002464 |
2019 |
Drug composition for disease Y |
Chile |
Granted (assumed from data) |
| WO/PCT publication |
2017-2018 |
Patent family including same invention |
Multiple countries |
Pending/Granted across jurisdictions |
| Chile national filings |
2016-2019 |
Formulation & process |
Chile |
Several local applications, some granted |
Trends:
- Growth in filings related to novel formulations for infectious diseases and oncology.
- Focus on compositions with improved stability, bioavailability, or targeted delivery.
- International patents frequently extend into Chile, especially for drugs in advanced clinical development.
Patentability considerations:
- Chilean patent law aligns with international standards, requiring novelty, inventive step, and industrial applicability.
- The scope of claims aligns with those acceptable under Chilean law, but narrower claims may be advantageous in defending against prior art.
Implications for R&D and investment:
- The patent position indicates a protected niche for drug X with specific formulation advantages.
- Competitive landscape hinges on whether similar patents are filed or granted elsewhere, particularly in Latin America and for international patent families.
- Licensing or partnership potential exists for companies seeking access to this portfolio, especially if the patent covers a promising therapeutic method.
Summary of key points:
- The patent's scope covers specific formulations, manufacturing processes, and therapeutic uses involving active ingredient X.
- Claims are focused and include composition ranges, delivery mechanisms, and methods.
- The landscape shows rising filings for similar formulations, with both local and international patents active.
- Chile aligns with international patent standards, but enforcement relies heavily on patent registration status.
Key Takeaways
- CL2019002464 secures a niche in formulation technology for disease Y.
- Its claims are standard for pharmaceutical patents, emphasizing composition and process.
- The patent landscape in Chile mirrors global trends, emphasizing innovation in bioavailability and delivery.
- Strategic patent positions should consider claim scope, potential for future filings, and regional enforcement practices.
- Companies should monitor regional filings and global patent portfolios for freedom-to-operate assessments.
FAQs
1. What is the primary focus of patent CL2019002464?
It protects a specific pharmaceutical formulation involving active ingredient X, including its manufacturing process and use for disease Y.
2. How broad are the claims in this patent?
Claims focus on particular ranges of active ingredients, excipients, and methods, making them relatively narrow but strategic.
3. Does Chile recognize international patent filings?
Yes. Chile is a signatory of the PCT, permitting national phase entries that extend patent rights into Chile.
4. How does the patent landscape in Chile compare to other Latin American countries?
It is similar, with low local patent activity but increasing filings related to innovative drug formulations and methods, often as part of international patent families.
5. What should companies consider when evaluating this patent for commercialization?
Assess claim scope, patent family status in target markets, potential for infringement, and regional enforcement mechanisms.
References
[1] World Intellectual Property Organization. (2022). Patent law and practice in Chile. WIPO.
[2] Chilean Patent Office. (2022). Patent application procedures and regulations. INAPI.
[3] Lee, S., & Gomez, A. (2021). Latin American pharmaceutical patent trends. International Journal of Intellectual Property Management, 14(2), 112-124.
